REQUEST A DEMO
Total
USD $0.00
Search more companies

Favimedica S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Favimedica S.A.S. Profile Updated: July 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Favimedica S.A.S. is an enterprise based in Colombia. Its main office is in Bogota D.C.. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on March 05, 1997. 1 (2025) employees currently work for Favimedica S.A.S.. In 2024, the company reported a net sales revenue increase of 26.72%. Its’ total assets recorded a growth of 10.92%. In 2024, Favimedica S.A.S.’s net profit margin decreased by 7.02%.

Headquarters
Cl 23D 75 49
Bogota D.C.; Bogota D.C; Postal Code: 0622

Contact Details: Purchase the Favimedica S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Favimedica S.A.S. report to view the information.
Registered Capital:
Purchase the Favimedica S.A.S. report to view the information.
Financial Auditors:
Purchase the Favimedica S.A.S. report to view the information.
Incorporation Date:
March 05, 1997
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Favimedica S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
26.72%
Total operating revenue
125.13%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-30.1%
Total Assets
10.92%
Total Equity
32.34%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-7.02%
Return on Equity (ROE)
-1.94%
Debt/Equity
-63.2%
Quick Ratio
-3055.78%
Cash Ratio
-126.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?